These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26002134)

  • 1. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.
    Cai M; Huang W; Lin C; Li Z; Qian J; Huang M; Zeng Z; Huang J; Shan H; Zhu K
    Eur Radiol; 2016 Feb; 26(2):370-80. PubMed ID: 26002134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients.
    Hayashi H; Beppu T; Masuda T; Mizumoto T; Takahashi M; Ishiko T; Takamori H; Kanemitsu K; Hirota M; Baba H
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1638-42. PubMed ID: 17683504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis.
    Hayashi H; Beppu T; Okabe K; Masuda T; Okabe H; Ishiko T; Baba H
    J Gastroenterol; 2010 May; 45(5):554-9. PubMed ID: 20047119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for complications after partial splenic embolization for liver cirrhosis.
    Hayashi H; Beppu T; Okabe K; Masuda T; Okabe H; Baba H
    Br J Surg; 2008 Jun; 95(6):744-50. PubMed ID: 18412294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large splenic volume may be a useful predictor for partial splenic embolization-induced liver functional improvement in cirrhotic patients.
    Hayashi H; Beppu T; Masuda T; Okabe H; Imai K; Hashimoto D; Ikuta Y; Chikamoto A; Watanabe M; Baba H
    J Hepatobiliary Pancreat Sci; 2014 Jan; 21(1):51-7. PubMed ID: 23798315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients.
    Zhu K; Meng X; Qian J; Huang M; Li Z; Guan S; Jiang Z; Shan H
    Dig Liver Dis; 2009 Jun; 41(6):411-6. PubMed ID: 19070555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients.
    N'Kontchou G; Seror O; Bourcier V; Mohand D; Ajavon Y; Castera L; Grando-Lemaire V; Ganne-Carrie N; Sellier N; Trinchet JC; Beaugrand M
    Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):179-84. PubMed ID: 15674095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study.
    Zhu K; Meng X; Li Z; Huang M; Guan S; Jiang Z; Shan H
    Eur J Radiol; 2008 Apr; 66(1):100-6. PubMed ID: 17532166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia.
    Lee CM; Leung TK; Wang HJ; Lee WH; Shen LK; Liu JD; Chang CC; Chen YY
    World J Gastroenterol; 2007 Jan; 13(4):619-22. PubMed ID: 17278231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced Hypersplenism.
    Jácome AA; Ohinata A; Mahvash A; Overman MJ; Kee B; Fogelman D; Morris VK; Johnson B; Rothschild ND; Wolff RA; Eng C
    Clin Colorectal Cancer; 2020 Dec; 19(4):e189-e199. PubMed ID: 32680816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of partial splenic embolization in cirrhotic patients.
    Sakai T; Shiraki K; Inoue H; Sugimoto K; Ohmori S; Murata K; Takase K; Nakano T
    Dig Dis Sci; 2002 Feb; 47(2):388-91. PubMed ID: 11855556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial splenic embolization for hypersplenism in cirrhotic patients. A case series.
    Omer S; Zara O; Iacobescu C; Dina I
    J Gastrointestin Liver Dis; 2014 Jun; 23(2):215-8. PubMed ID: 24949616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization.
    Kim NH; Kim HJ; Cho YK; Hong HP; Kim BI
    J Korean Med Sci; 2019 Aug; 34(30):e208. PubMed ID: 31373186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism.
    Noguchi H; Hirai K; Aoki Y; Sakata K; Tanikawa K
    Hepatology; 1995 Dec; 22(6):1682-8. PubMed ID: 7489974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of partial splenic embolization in children.
    Nio M; Hayashi Y; Sano N; Ishii T; Sasaki H; Ohi R
    J Pediatr Surg; 2003 Dec; 38(12):1760-2. PubMed ID: 14666461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in splenic volume after partial splenic embolization in children.
    Watanabe Y; Todani T; Noda T
    J Pediatr Surg; 1996 Feb; 31(2):241-4. PubMed ID: 8938350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia.
    Abdella HM; Abd-El-Moez AT; Abu El-Maaty ME; Helmy AZ
    Indian J Gastroenterol; 2010 Mar; 29(2):59-61. PubMed ID: 20443100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial splenic embolization in the treatment of prolonged thrombocytopenia due to hypersplenism in metastatic cancer patients.
    Passhak M; Shachar SS; Ofer A; Beny A
    Support Care Cancer; 2018 Oct; 26(10):3527-3532. PubMed ID: 29696427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role and evolution of partial splenic embolization over three decades: A multicentric retrospective single cohort study of 90 patients from French nationwide experience.
    Leideck P; Nkontchou G; Elkrief L; Erard D; d'Alteroche L; Radenne S; Billioud C; Meszaros M; Regnault D; Pageaux GP; Hilleret MN; Tripon S; Guillaud O; Ollivier-Hourmand I; Ganne-Carrié N; Dumortier J
    Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102355. PubMed ID: 38679291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of preoperative partial splenic embolization in hepatocellular carcinoma and hypersplenic thrombocytopenia.
    Yoshidome H; Kimura F; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Suda K; Takano S; Miyazaki M
    Hepatogastroenterology; 2011; 58(112):2062-6. PubMed ID: 22234078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.